Depending on the formulation and individual risk factors, estrogen-containing therapies may increase the likelihood of venous blood clots and, in selected people, stroke or other cardiovascular complications.
Risk is influenced by factors such as:
Depending on the formulation and individual risk factors, estrogen-containing therapies may increase the likelihood of venous blood clots and, in selected people, stroke or other cardiovascular complications.
Risk is influenced by factors such as: